Chapman University

Chapman University Digital Commons
Athletic Training Faculty Articles and Research

Athletic Training

11-2016

Creatine Kinase, Exertional Rhabdomyolysis, and
Exercise-Associated Hyponatremia in UltraEndurance Athletes: A Critically Appraised Paper
Michelle A. Cleary
Chapman University, cleary@chapman.edu

Follow this and additional works at: http://digitalcommons.chapman.edu/athletic_training_articles
Part of the Sports Sciences Commons
Recommended Citation
Cleary, M.A. (2016). Creatine kinase, exertional rhabdomyolysis, and exercise-associated hyponatremia in ultra-endurance athletes: A
critically appraised paper. International Journal of Athletic Therapy and Training, 21(6), 13-15. doi: 10.1123/ijatt.2015-0071

This Article is brought to you for free and open access by the Athletic Training at Chapman University Digital Commons. It has been accepted for
inclusion in Athletic Training Faculty Articles and Research by an authorized administrator of Chapman University Digital Commons. For more
information, please contact laughtin@chapman.edu.

Creatine Kinase, Exertional Rhabdomyolysis, and Exercise-Associated
Hyponatremia in Ultra-Endurance Athletes: A Critically Appraised Paper
Comments

This is a pre-copy-editing, author-produced PDF of an article accepted for publication in International Journal
of Athletic Therapy and Training, volume 21, issue 6, in 2016 following peer review. The definitive publisherauthenticated version is available online at DOI: 10.1123/ijatt.2015-0071.
Copyright

Human Kinetics

This article is available at Chapman University Digital Commons: http://digitalcommons.chapman.edu/athletic_training_articles/15

Running Head: Rhabdomyolysis in Ultra-Endurance Athletes

Creatine Kinase, Exertional Rhabdomyolysis, and Exercise-Associated Hyponatremia in
Ultra-Endurance Athletes: A Critically Appraised Paper
Michelle Cleary, PhD, ATC
Chapman University

Direct Correspondence to:
Michelle A. Cleary PhD, ATC
Associate Dean of Graduate Programs
Crean College of Health and Behavioral Science
Chapman University
One University Drive
Orange, CA 92866
Phone: 714-628-2797
Email: cleary@chapman.edu
Submitted to:
International Journal of Athletic Therapy and Training
On:
September 1, 2015

Rhabdomyolysis in Ultra-Endurance Athletes
Page 1

Running Head: Rhabdomyolysis in Ultra-Endurance Athletes
BLIND TITLE PAGE
Creatine Kinase, Exertional Rhabdomyolysis, and Exercise-Associated Hyponatremia in
Ultra-Endurance Athletes: A Critically Appraised Paper

Rhabdomyolysis in Ultra-Endurance Athletes
Page 2

Creatine Kinase, Exertional Rhabdomyolysis, and Exercise-Associated Hyponatremia in
Ultra-Endurance Athletes: A Critically Appraised Paper
Clinical Scenario
Exercise-associated muscle damage results in elevated plasma creatine kinase (CK), often
diagnosed as exertional rhabdomyolysis (ER) in runners. Likewise, exercise-associated
hyponatremia (EAH) is prevalent in ultra-endurance racers. A link has been proposed between
ER and EAH in that the simultaneous presentation of EAH and ER creates a complicated and
opposing treatment paradox regarding fluid resuscitation.
Focused Clinical Question
What is the relationship between EAH and ER in ultra-endurance athletes?
Search Strategy
 The database searched was Pub Med
 The following keywords were used: creatine kinase, athletes, muscle damage, exerciseinduced muscle damage and rhabdomyolysis
 The criteria for study selection were: human subjects, peer-reviewed, English language,
published within last 2 years
 Critical appraisal was conducted according to the Oxford Center for Evidence-Based
Medicine (OCEBM) and the Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement.
Study Selected
 Chlibkova D, Knechtle B, Rosemann T, et al. Rhabdomyolysis and exercise-associated
hyponatremia in ultra-bikers and ultra-runners. J Int Soc Sports Nutr. 2015;12:29.
DOI 10.1186/s12970-015-0091-x. Published online June 25, 2015.
Evidence Quality Assessment
This investigation utilized a multiple-group, non-randomized, cohort-control research design, or
a Level 2b according OCEBM. The STROBE statement was used to assess the quality of this
study, which met 19/22 of the criteria.
Study Patients and Sampling. Subjects were 113 ultra-endurance athletes participating in a
variety of ultra-events (ultra-mountain bikers: stage racers and 24-hr ultra-bikers; ultra-runners:
24-hr ultra- and 100-km ultra-runners). The study included 6 race finishers with rhabdomyolysis
as diagnosed by blood CK levels >10,000 U/L without the development of renal failure or
necessity of medical treatment.
Control Group. The control group consisted of 100 normonatremic ultra-athletes who
completed their respective event and provided a complete data set of blood and urine samples.
Of the normonatremic finishers, 4 (4 %) ultra-runners (all men) developed ER.
Experimental Group. The researchers found 13 hyponatremic athletes diagnosed with postrace plasma [Na+] <135 mmol/L with 2 (15.4 %, one man and one woman) who developed ER.
Outcome Measures. Athletes agreed to provide blood and urine measurements during
registration the day before each race and upon completion of the race. Blood samples were
analyzed for plasma [Na+], [K+], CK, and urine creatinine; only CK and [Na+] are reported here.
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Clinical Bottom Line(s)
1. Of the ultra-endurance race finishers in this study (n=113), 5.3% developed ER with CK
>10,000 U/L and 15.9 % developed ER/myopathy (CK >2,000 U/L). Of the ultra-runners,
28.6% (6/21) developed ER and none of the ultra-mountain bikers. Hyponatremic ultraathletes developed ER more often than normonatremic ultra-athletes.
2. Due to the wide inter-individual ranges of CK and the excessively high CK in asymptomatic
ultra-athletes, the value of CK as a prognostic or diagnostic tool is questionable.
3. In situations where the diagnosis of EAH is uncertain, treatment with fluid restriction is
contraindicated in case of dehydration and ER which may lead to acute kidney injury.
Implications for Practice, Education, and Future Research
The overall incidence rate of ER was 5.3% (6/113) in ultra-endurance race finishers and 28.6%
(6/21) of ultra-runners. Ultra-athletes who developed ER had an average post-race CK=
18,423.6±6,138.8 U/L (range= 12,786.2-29,702.9 U/L). These ranges for post-race CK far
exceed the 5-10 times upper limit of normal for CK for diagnosis of ER, indeed these athletes
had 9,659.0±8,793.3% (2,665.0±26,209.0%) increased CK from baseline. Further, the ultrarunners who did not present with ER also reported with exceedingly high CK, but were
asymptomatic. The table below was calculated in aggregate from the data provided by the
researchers and includes the plasma [Na+] and CK averages, ranges, and % change from
baseline for all ultra-race finishers. In the EAH and ER group, post-race CK increased
7,160.3±6,238.4% (2,749.0±11,571.5%) from pre-race while in the ER only group post-race CK
increased 10,908.4±10,471% (2,665.0-26,209.0) from pre-race. In all the ultra-runners (n=21)
CK increased 3,365.8±4,098.7% (990.7-5,782.1%) from pre-race while in all the mountain
bikers (n=82) CK increased 458.9±511.3% (308.1-590.9%) from pre-race. The total finished
ultra-marathons, total hours spent training weekly, and gender were related to post-race CK
concentration (P >0.05) in both groups.
Comments: The major strengths of this investigation were external validity or the
generalizability of the sample of the large variety of ultra-endurance events and the number and
quality of the variables assessed. Fortunately, none of the ultra-runners who developed ER
required medical intervention. The major limitation of this investigation was the small sample
size for the athletes who developed ER, as expected with the low incidence rate of this condition
in well-trained athletes. Furthermore, the investigators did not confirm the presence of
myoglobinuria, although this clinical indicator is less sensitive and not clinically useful. Finally,
following the subjects for an additional 24-72 hr would have likely demonstrated increased CK, a
reliable clinical indicator of more severe rhabdomyolysis.
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Table. Post-race plasma sodium [Na+] and creatine kinase (CK) in ultra-endurance athletes
Event
Pre-Race [Na+]
Post-Race [Na+] %change from Pre-Race CK
(gender)
(mmol/L)
(mmol/L)
Pre-Race
(mmol/L)
Athletes* with
M±SD 137.5±0.7
133.5±0.7
-2.9±0.0
319.7±268.3
EAH
and ER
Range 137.0-138.0
133.0-134.0
-2.9
130.0-509.4
(n=2, all men)
Athletes* with
M±SD 139.0±1.8
138.0±2.4
-0.7±3.0
309.9±246.8
ER
(n=4, 2 men,
Range 137.0-141.0
135.0-141.0
-4.3 to 2.9
112.9-654.1
2 women)
Ultra-Mountain M±SD 140.0±2.1
138.1±2.3
-1.3±1.9
164.0±72.3
Bikers
(n=82, 66 men, Range 137.5-142.8
136.6-140.0
-1.9 to -0.6
118.9-207.5
16 women)
Ultra-Runners
M±SD 139.5±2.1
137.7±2.5
-0.6±2.2
200.3±138.0
(n=21, 12 men, Range 138.4-140.1
136.0-139.1
-1.7 to 1.3
99.0-251.1
9 women)
Note. EAH= exercise-associated hyponatremia, ER= Exertional rhabdomyolysis
*All athletes who developed ER were ultra-runners

Post-Race CK
(mmol/L)
14,842.9±466.7

%change from
Pre-Race
7,160.3±6,238.4

14,512.9±15,172.9

2,749.0±11,571.5

20,213.9±7,065.0

10,908.4±10,471.5

12,786.2-29,702.9

2,665.0-26,209.0

828.2±657.8

458.9±511.3

418.1-1,316.3

308.1-590.9

5,156.8±6,079.2
1,949.3-8,813.8

3,365.8±4,098.7
990.7-5,782.1

